Inventor · disambiguated record
Courtney Houchen
Also filed as: HOUCHEN COURTNEY · HOUCHEN COURTNEY W
11 granted patents·3 pending applications·18 citations·filing 2009–2025
85Inventor score
Top patents by PatentIndex Score
14 records- 0190US11672789B2Radiation mitigator and method of use thereofUNIV GEORGETOWN·Filed 2022·Granted Jun 13, 2023·1 cites·18 claims
- 0283US12415867B2Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereofUNIV OKLAHOMA·Filed 2024·Granted Sep 16, 2025·0 cites·18 claims
- 0383US12246011B2Radiation mitigator and method of use thereofUNIV GEORGETOWN·Filed 2023·Granted Mar 11, 2025·0 cites·18 claims
- 0481US7902166B2Compositions comprising inhibitors of RNA binding proteins and methods of producing and using sameUNIV OKLAHOMA STATE·Filed 2009·Granted Mar 8, 2011·4 cites·11 claims
- 0579US11311526B2Radiation mitigator and method of use thereofUNIV GEORGETOWN·Filed 2017·Granted Apr 26, 2022·2 cites·16 claims
- 0674US8198255B2SiRNA-mediated inhibition of doublecortin and Ca2+/calmodulin-dependent kinase-like-1HOUCHEN COURTNEY·Filed 2009·Granted Jun 12, 2012·5 cites·12 claims
- 0772US7956044B1Compositions comprising inhibitors of RNA binding proteins and methods of producing and using sameUNIV OKLAHOMA·Filed 2009·Granted Jun 7, 2011·1 cites·11 claims
- 0871US9663585B2Anti-DCLK1 monoclonal antibodies and methods of production and use thereofUNIV OKLAHOMA·Filed 2013·Granted May 30, 2017·2 cites·14 claims
- 0970US2025177368A1Radiation mitigator and method of use thereofUNIV GEORGETOWN·Filed 2025·Application pending·0 cites
- 1068US11655307B2Anti-doublecortin-like kinase 1 antibodies and methods of useUNIV OKLAHOMA·Filed 2018·Granted May 23, 2023·1 cites·22 claims
- 1167US12084514B2Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereofUNIV OKLAHOMA·Filed 2018·Granted Sep 10, 2024·0 cites·11 claims
- 1262US8936941B2Compositions useful for cancer detection and treatment, a cancer stem cell model, and methods of production and use thereofANANT SHRIKANT·Filed 2011·Granted Jan 20, 2015·2 cites·5 claims
- 1354US2023338348A1Renin-angiotensin system (ras) modulators for treatment of viral infections, pharmaceutical compositions including the same, and methods of treating using the sameTROCAR PHARMA INC·Filed 2021·Application pending·0 cites
- 1437US2019218603A1Microrna expression signatures for doublecortin-like kinase 1 (dclk1) activityUNIV OKLAHOMA·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →